VALENTINO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 4.523
AS - Asia 2.656
EU - Europa 986
SA - Sud America 759
Continente sconosciuto - Info sul continente non disponibili 187
AF - Africa 62
OC - Oceania 3
Totale 9.176
Nazione #
US - Stati Uniti d'America 4.348
SG - Singapore 1.215
CN - Cina 615
BR - Brasile 584
IT - Italia 384
VN - Vietnam 331
IN - India 248
GB - Regno Unito 138
CA - Canada 126
SE - Svezia 123
DE - Germania 121
AR - Argentina 75
BD - Bangladesh 52
FI - Finlandia 52
HK - Hong Kong 47
ID - Indonesia 34
EC - Ecuador 33
RU - Federazione Russa 29
MX - Messico 23
NL - Olanda 23
UA - Ucraina 22
ZA - Sudafrica 19
CO - Colombia 17
FR - Francia 17
JP - Giappone 17
PK - Pakistan 16
IQ - Iraq 15
ES - Italia 13
PL - Polonia 13
VE - Venezuela 13
CL - Cile 12
JM - Giamaica 10
MA - Marocco 10
RO - Romania 10
PY - Paraguay 9
EG - Egitto 8
UY - Uruguay 8
SA - Arabia Saudita 7
TN - Tunisia 7
AT - Austria 6
PE - Perù 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
EE - Estonia 5
IE - Irlanda 5
NP - Nepal 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
JO - Giordania 4
KE - Kenya 4
DZ - Algeria 3
GR - Grecia 3
IR - Iran 3
KR - Corea 3
PH - Filippine 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
CH - Svizzera 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
IL - Israele 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MK - Macedonia 2
PT - Portogallo 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TV - Tuvalu 1
Totale 8.992
Città #
San Jose 793
Chandler 442
Ashburn 357
Singapore 354
Dallas 320
Santa Clara 233
Bengaluru 185
Council Bluffs 184
Hefei 183
Milan 155
Princeton 150
Lawrence 149
Ho Chi Minh City 126
Chicago 118
London 108
Munich 98
Beijing 95
Wilmington 76
Ottawa 75
Hanoi 74
Des Moines 59
Boardman 49
Phoenix 44
São Paulo 44
Hong Kong 43
Los Angeles 39
New York 38
Turku 35
Shanghai 22
Guangzhou 19
Haiphong 16
Brasília 15
Helsinki 15
Rome 15
San Francisco 15
Hải Dương 14
Norwalk 14
Shenzhen 14
Buffalo 13
Chennai 13
Orem 13
Rio de Janeiro 13
Salvador 13
The Dalles 13
Atlanta 12
Catanzaro 12
Curitiba 12
Quito 12
Rossano 12
Tokyo 12
Amsterdam 11
Brooklyn 11
Guayaquil 11
Toronto 11
Augusta 10
Boston 10
Secaucus 10
Thái Bình 10
Campinas 9
Da Nang 9
Mexico City 9
Montreal 9
Pune 9
Warsaw 9
Aversa 8
Biên Hòa 8
New Delhi 8
Quảng Ngãi 8
Seattle 8
Belo Horizonte 7
Denver 7
Houston 7
Johannesburg 7
Montevideo 7
Naples 7
Newark 7
Stockholm 7
Baghdad 6
Bari 6
Bắc Giang 6
Caracas 6
Columbus 6
Horia 6
Kingston 6
Lahore 6
Manaus 6
Philadelphia 6
Porto Alegre 6
Redmond 6
Rui'an 6
Xian 6
Diadema 5
Genoa 5
Jakarta 5
Jeddah 5
Jiaxing 5
Las Vegas 5
Medellín 5
Ninh Bình 5
Sorocaba 5
Totale 5.298
Nome #
Microstructural alterations of the spinothalamic tract and neuropathic pain: A diffusion tensor imaging study in relapsing remitting multiple sclerosis 124
PRECLINICAL MARKERS OF NEUROPATHIC DAMAGE IN TYPE 1 DIABETES MELLITUS 110
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chomosome 1 101
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1 95
A. Spinal muscular atrophy due to an isolated deletion of Exon 8 of telomeric survival motor neuron gene 86
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 86
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 82
Efficacy of Transcranial Direct Current Stimulation (tDCS) on Balance and Gait in Multiple Sclerosis Patients: A Machine Learning Approach 81
A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association? 78
Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene 76
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables 75
Assessment of the Corticospinal Tract Profile in Pure Lower Motor Neuron Disease: A Diffusion Tensor Imaging Study 75
Calf pseudohypertrophy in a patient with double neurogenic pathology 73
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia 73
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 72
Superior Cerebellar Peduncle Atrophy Predicts Cognitive Impairment in Relapsing Remitting Multiple Sclerosis Patients with Cerebellar Symptoms: A DTI Study 72
Two cases of unilateral wasting and weakness of distal upper limb: Similar onset and different diagnosis in young patients 71
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 71
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: A 18-month multicentre study 71
Anti-GAD associated inflammatory myopathy presenting with dropped head syndrome 70
Blink reflex recovery cycle in patients with dystonic tremor: a cross-sectional study 69
An axon regeneration signature in a Charcot-Marie-Tooth disease type 2 patient. 67
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 67
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 66
Alternating pattern distinguishes resting tremor of Parkinson’s disease from rest tremor associated with essential tremor 66
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 66
The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis 65
Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report. 64
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 64
Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data 62
Genetics heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern 61
Adaptive cortical changes and the functional correlates of visuo-motor integration in relapsing-remitting multiple sclerosis 60
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 60
Action palatal tremor in a patient with primary intestinal lymphoma 60
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease. 60
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 60
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 60
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 59
Blink reflex recovery cycle in patients with essential tremor associated with resting tremor. 59
Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates 59
Alterazioni istopatologiche ed ultrastrutturali nel connettivo subsinoviale nella sindrome del tunnel carpale idiopatica 59
Thalamic tremor as onset of vascular parkinsonism 59
Palatal tremor in a patient with primary intestinal lymphoma 59
Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study 58
Genetic heterogeneity in autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B) 58
Kufs’ disease presenting as late-onset epilepsia partialis continua 58
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 57
A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy 57
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis 57
TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis. 57
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 56
ACTION PALATAL TREMOR IN PATIENT WITH PRIMARY INTESTINAL LYMPHOMA 56
Negative myoclonus during valproate-related stupor. Neurophysiological evidence of a cortical non-epileptic origin. 56
Tractography in amyotrophic lateral sclerosis using a novel probabilistic tool: A study with tract-based reconstruction compared to voxel-based approach 56
Blink reflex recovery cycle distinguishes essential tremor with resting tremor from de novo Parkinson's disease 56
Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. 55
The corticospinal tract profile in amyotrophic lateral sclerosis 55
Camptocormia as presenting in lower motor neuron disease with TARDBP mutation: case report. 55
LACK OF ASSOCIATION BETWEEN ESTROGEN RECEPTOR 1 GENE POLYMORPHISMS AND MULTIPLE SCLEROSIS IN SOUTHERN ITALY IN HUMANS 55
CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2): early impairment of Wisconsin Card Sorting Test and saccade velocity 55
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 55
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 54
PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker. 54
Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis 54
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis 54
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 53
Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study 53
Temporal lobe epilepsy as a unique manifestation of multiple sclerosis 53
An exploration of anger phenomenology in multiple sclerosis. 53
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability 52
The effects of BDNF Val66Met polymorphism on brain fuction in controls and patients with multiple sclerosis: an imaging genetic study. 52
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 52
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab 52
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study 51
A new SBF2 mutation in a family with recessive demielinating Charcot-Marie-Tooth (CMT4B2) 51
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 51
Correction to: Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease 50
Clinical and genetic study of a large Charcot-Marie-Tooth type 2° family southern Italy 50
Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths 50
Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis 49
Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study 49
A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL 49
Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis 49
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis 48
GENETIC HETEROGENEITY IN AUTOSOMAL RECESSIVE HEREDITARY MOTOR AND SENSORY NEUROPHATY WITH FOCALLY FOLDED MYELIN SHEATHS (CMT4B) 48
Genetic screening for familial amyloid polyneuropathy in patients with idiopathic carpal tunnel syndrome 48
Preliminary evidences of a NOS2A protective effect from Relapsing-Remitting Multiple Sclerosis 48
Clinical spectrum and frequency of Charcot–Marie–Tooth disease in Italy: Data from the National CMT Registry 47
An unusual ALS onset with hyperhidrosis as first clinical manifestation 47
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 47
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients 47
Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy 47
A Cellular Neural Network methodology for the automated segmentation of multiple sclerosis lesions. 47
Brain atrophy and lesion load in a large population of patients with multiple sclerosis 47
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy 47
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs. 46
The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls. 46
Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH 46
Cognitive deficits in multiple sclerosis patients with cerebellar symptoms 46
Histopathological, Clinical, and Electrophysiological Features Influencing Postoperative Outcomes in Carpal Tunnel Syndrome 46
Totale 6.018
Categoria #
all - tutte 86.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022322 0 0 0 82 37 3 8 79 30 17 64 2
2022/20231.202 309 26 32 133 161 116 1 76 173 74 75 26
2023/2024497 111 79 47 27 30 135 23 4 3 10 2 26
2024/20251.819 231 114 110 76 129 225 33 68 250 120 160 303
2025/20264.242 196 460 552 850 396 123 499 235 505 228 148 50
2026/2027780 46 190 402 142 0 0 0 0 0 0 0 0
Totale 9.176